#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia Aspergillus infection Primary mediastinal large B-cell lymphoma Erythema Cervix carcinoma Glomerulonephritis acute Familial hypertriglyceridaemia Transient ischaemic attack Immunodeficiency congenital Chondrosarcoma metastatic Monogenic diabetes Idiopathic intracranial hypertension SAPHO syndrome Epilepsy with myoclonic-atonic seizures Short stature homeobox gene mutation More trials…

    Learn about Rare Diseases

    Pemphigoid – Diagnostics Haemophilia B with anti factor IX – Treatment Activated PI3 kinase delta syndrome – Diagnostics Erdheim-Chester disease Cystic fibrosis Nephroblastoma – Basic Information Glomerulonephritis membranoproliferative Waldenstrom’s macroglobulinaemia refractory – Treatment Methylmalonic acidaemia – Life with Disease Atypical haemolytic uraemic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Favezelimab Olaparib Autogene Cevumeran Naltrexone Hydrochloride Apadamtase Alfa Alternaria Alternata Extract Pitavastatin Calcium Dog Epithelium Extract Amitriptyline Oxygen Ph.eur. Chloride Ion Resamirigene Bilparvovec Specific Nucleic Acid Sna-Her1 Aluminium Hydroxide Dutasteride Procarbazine Hydrochloride D5-Ethyl-Beta-D-Glucuronide Bupivacaine Treprostinil Sodium Carisbamate More therapies…

    Learn about Your Condition

    Thymoma Psychological trauma Liposarcoma Ewing's sarcoma recurrent Pemphigoid Chronic lymphocytic leukaemia Noonan syndrome Persistent depressive disorder Cervix carcinoma stage II CDKL5 deficiency disorder Thrombocytopenia Neuroendocrine carcinoma Bone hypertrophy Pseudomonas infection Adenocarcinoma of colon More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    • Risankizumab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • GRISNILIMAB SETARITOX
    The Netherlands

  • Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on the Effects of Sirolimus Cream for Patients with Port Wine Stains

    Recruiting

    2 1 1
    Investigated Diseases:
    • Naevus flammeus
    Investigated Drugs:
    • Sirolimus
    Spain

  • Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

    Recruiting

    3 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • POTASSIUM HYDROXIDE
    Germany
Previous Page
1 … 7 8 9 10 11 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!